COMMUNIQUÉS West-GlobeNewswire

Vera Therapeutics Announces Closing of Upsized Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares in Public Offering of Class A Common Stock
01/02/2024
BRISBANE, Calif., Feb. 01, 2024 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (“Vera”), a late clinical-stage biotechnology company developing and commercializing transformative treatments for patients with serious [...]
IRADIMED CORPORATION to Hold 2023 Fourth Quarter Financial Results Conference Call on February 8th.
01/02/2024
WINTER SPRINGS, Fla., Feb. 01, 2024 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2023 fourth quarter financial results before the market opens on Thursday, [...]
X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
01/02/2024
BOSTON, Feb. 01, 2024 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals (Nasdaq: XFOR), a company driven to improve the lives of people with rare diseases of the immune system, today announced that, effective on January 31, 2024, [...]
Seer to Report Fourth Quarter and Full Year 2023 Financial Results on February 29, 2024
01/02/2024
REDWOOD CITY, Calif., Feb. 01, 2024 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today announced that it will report financial [...]
Revolution Medicines to Participate in Upcoming Investor Conferences
01/02/2024
REDWOOD CITY, Calif., Feb. 01, 2024 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing targeted therapies for RAS-addicted cancers, today announced that Mark A. [...]
Nurix Therapeutics Announces Publication in the Journal Science Identifying a New Class of BTK Mutations That Are Susceptible to NX-2127, a Novel BTK and IKZF1/3 Degrader
01/02/2024
Data reveal oncogenic scaffold function of BTK mutations that lack kinase activity and show these mutations remain susceptible to degradation by NX-2127 NX-2127 degrades BTK in patients regardless of mutational status [...]
NewAmsterdam Pharma to Present at Guggenheim Healthcare Talks 6th Annual Biotechnology Conference
01/02/2024
NAARDEN, the Netherlands and MIAMI, Feb. 01, 2024 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical company developing oral [...]
TCG Labs-Soleil Raises Inaugural Fund of Over $400 Million
01/02/2024
Launches a Novel ‘Venture-Biotech’ Model, Creating an Integrated Ecosystem To Exclusively Fund, Discover, and Develop Single-Asset Biologic Therapies SAN FRANCISCO, Feb. 01, 2024 (GLOBE NEWSWIRE) -- TCG Labs-Soleil , in [...]
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
01/02/2024
Bagsværd, Denmark, 1 February 2024 — This company announcement discloses the data of the transaction(s) made in Novo Nordisk shares by the company’s board members, executives and their associated persons in accordance [...]
SweetWater Brewing and Pullman Yards Present 420 Fest on April 20 & 21, 2024
01/02/2024
SweetWater 420 Fest is Back Featuring 25+ Artists ATLANTA, Feb. 01, 2024 (GLOBE NEWSWIRE) -- SweetWater Brewing Company (“SweetWater Brewing” or “SweetWater”), the largest craft brewer in the Southeast and a subsidiary [...]
Crossject to host a business briefing on commercial strategy on February 6 at 17:30 CET
01/02/2024
Dijon, France, February 1, 2024 -- 18:15 CET - Crossject (ISIN: FR0011716265; Euronext: ALCJ), a specialty pharma company developing needle-free auto-injectors for emergency situations, will hold a conference call on [...]
Crossject organisera un webcast le 6 février à 17h30 pour faire le point sur sa stratégie commerciale
01/02/2024
Dijon, France, 1 février 2024 – 18 : 15 CET - Crossject (ISIN : FR0011716265 ; Euronext : ALCJ), une société pharmaceutique spécialisée qui développe des auto-injecteurs sans aiguille dédiés aux situations d’urgence, [...]
EssilorLuxottica: Full-Year 2023 Results Conference Call Invitation
01/02/2024
Full-Year 2023 Results Conference Call Invitation Mr FRANCESCO MILLERI, Chairman and Chief Executive Officer, Mr PAUL DU SAILLANT, Deputy Chief Executive Officer, Mr STEFANO GRASSI, Chief Financial Officer, and Mr [...]
Number of votings rights as of January 31 2024
01/02/2024
Nicox SA Société anonyme with a registered capital of € 50,186,094 Head Office: DRAKKAR D 2405 route des Dolines 06560 Valbonne Sophia-Antipolis  R.C.S. GRASSE 403.942.642 On February 1st, 2024, MONTHLY PUBLICATION OF [...]
Nombre de droits de vote au 31 janvier 2024
01/02/2024
Nicox SA Société anonyme au capital de 50 186 094 euros Siège social : DRAKKAR D 2405 route des Dolines 06560 Valbonne Sophia-Antipolis  R.C.S. GRASSE 403.942.642 Le 1er février 2024, PUBLICATION MENSUELLE DU NOMBRE D’ [...]
GT Biopharma, Inc. Announces 1-for-30 Reverse Stock Split
01/02/2024
BRISBANE, CALIFORNIA, Feb. 01, 2024 (GLOBE NEWSWIRE) -- GT Biopharma, Inc. (NASDAQ: GTBP) (the “Company”), a clinical stage immuno-oncology company focused on developing innovative therapeutics based on the Company's [...]
Alira Health Releases Global Report on Robotic-Assisted Surgery (RAS) in Orthopedic Procedures
01/02/2024
Analysis reveals the market is anticipated to grow 10% annually over the next five years, reaching more than 2.6 million procedures in the EU, UK and US alone FRAMINGHAM, Mass., Feb. 01, 2024 (GLOBE NEWSWIRE) -- Alira [...]
Enlitic® Announces Appointment of Steve Rankin as Chief Strategy Officer
01/02/2024
Rankin to drive Enlitic’s product and market strategies for future growth. FORT COLLINS, Colo. and MELBOURNE, Australia, Feb. 01, 2024 (GLOBE NEWSWIRE) -- Enlitic, Inc. , (ASX:ENL) a leading innovator in data [...]
Myriad Genetics Completes Acquisition of Precise Tumor, Precise Liquid and Laboratory from Intermountain Precision Genomics
01/02/2024
SALT LAKE CITY, Feb. 01, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. , (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced it has completed the acquisition from Intermountain Health of [...]

Pages